News Highlights
Thought Leadership
February 18 2020SAD or MAD But Not Alone: Medical Writing for Small Biotechs
January 17 2020Giving Back with Tutoring Plus
December 18 2019PM Considerations for NDA/MAA Submissions
Upcoming Events
2020 Rare Disease Day
February 28 2020Boston, MA- April 6-7 2020 Cambridge, MA
Chief Medical Officer Summit 2020
- June 3-4 2020 Cambridge, MA
AICROS Annual Meeting
Heather Paden, MS
“PROMETRIKA acts as an agile and synergistic extension of your team for clinical trials. We provide the leadership and trial oversight that seamlessly streamlines communication, ensures regulatory compliance, prevents delays, and can minimize costs. We’ve collaborated on over 1,000 phase 1 to phase 4 clinical trials and achieved new drug approvals by the U.S. FDA and European regulatory agencies. Well-versed in studies of all therapeutic areas, we have specialized expertise in rare disease and oncology clinical trials.”
Heather Paden, MS
SPECIALIZED SERVICES
FOCUS ON RARE DISEASES
We have experience in rare disease clinical trials that includes more than 60 studies in a broad range of indications.
FOCUS ON ONCOLOGY
Oncology represents one of PROMETRIKA’s top three therapeutic areas of experience.
OUR STORY
PROMETRIKA was founded in 2003 and started operations as a data management, biostatistics, and medical writing functional service provider. In 2007, we added clinical operations and pharmacovigilance and became a full-service Clinical Research Organization. Since then, PROMETRIKA has provided more than a decade of experienced, professional support to local, national, and international clients and has gained a reputation for quality and excellence. Let us tell you about our journey!